These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 9184166
1. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Najjar SM, Blakesley VA, Li Calzi S, Kato H, LeRoith D, Choice CV. Biochemistry; 1997 Jun 03; 36(22):6827-34. PubMed ID: 9184166 [Abstract] [Full Text] [Related]
2. Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. Freund GG, Kulas DT, Mooney RA. J Immunol; 1993 Aug 15; 151(4):1811-20. PubMed ID: 7688386 [Abstract] [Full Text] [Related]
7. The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor. Soni P, Lakkis M, Poy MN, Fernström MA, Najjar SM. Mol Cell Biol; 2000 Jun 26; 20(11):3896-905. PubMed ID: 10805733 [Abstract] [Full Text] [Related]
9. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors. Takata Y, Kobayashi M. Diabete Metab; 1994 Jun 26; 20(1):31-6. PubMed ID: 8056133 [Abstract] [Full Text] [Related]
10. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Maile LA, Clemmons DR. Circ Res; 2003 Nov 14; 93(10):925-31. PubMed ID: 14563713 [Abstract] [Full Text] [Related]
11. Molecular dynamics of insulin/IGF-I receptor transmembrane signaling. Pessin JE, Frattali AL. Mol Reprod Dev; 1993 Aug 14; 35(4):339-44; discussion 344-5. PubMed ID: 8398111 [Abstract] [Full Text] [Related]
12. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT. Mol Cell Biol; 2007 May 14; 27(10):3569-77. PubMed ID: 17325037 [Abstract] [Full Text] [Related]
13. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905. Li S, Zhang H, Hoff H, Sell C. Exp Cell Res; 1998 Sep 15; 243(2):326-33. PubMed ID: 9743592 [Abstract] [Full Text] [Related]
14. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Johansson GS, Arnqvist HJ. Am J Physiol Endocrinol Metab; 2006 Nov 15; 291(5):E1124-30. PubMed ID: 16803852 [Abstract] [Full Text] [Related]
16. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Dews M, Nishimoto I, Baserga R. Recept Signal Transduct; 1997 Nov 15; 7(4):231-40. PubMed ID: 9633824 [Abstract] [Full Text] [Related]
19. Prolonged vs transient roles for early cell cycle signaling components. Rose DW, Xiao S, Pillay TS, Kolch W, Olefsky JM. Oncogene; 1998 Aug 20; 17(7):889-99. PubMed ID: 9780005 [Abstract] [Full Text] [Related]
20. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Hongo A, D'Ambrosio C, Miura M, Morrione A, Baserga R. Oncogene; 1996 Mar 21; 12(6):1231-8. PubMed ID: 8649825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]